Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hester Biosciences Nepal is a joint venture between Hester Biosciences India and the Golchha Group, specializing in the manufacture of veterinary vaccines. The company operates a state-of-the-art manufacturing facility in Kavre, Nepal, which is one of the largest and most advanced animal vaccine plants in the region. Its product portfolio primarily focuses on vaccines for livestock and poultry, including a globally significant PPR (Peste des Petits Ruminants) vaccine used in international eradication programs. Hester Biosciences Nepal serves the domestic Nepalese market and exports its products to various countries in Africa and Asia, often through global tenders from organizations like the FAO. The company plays a vital role in enhancing animal health and supporting the livestock economy through high-quality biological products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hester Biosciences Nepal.